This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Cell Death Pathways: Apoptosis, Autophagy and Necrosis
joint with Metabolism and Cancer Progression
Organizer(s): Guido Kroemer, Junying Yuan and Eileen P. White
Date: March 12 - 17, 2010
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by Astellas Pharma Inc. and Genentech BioOncology
Summary of Meeting:
Homeostatic and pathological cell death can occur through a multiplicity of different mechanisms including apoptosis, autophagy, necrosis and others. The morphological and functional definitions of distinct cell death modalities are emerging, and the relationships between different lethal pathways are being determined. However, the exact nature of the molecular switches that determine which subroutines cells disintegrate are elusive. Moreover, the relative contributions of different cell death modalities to the avoidance of cancer or degenerative diseases remain to be defined. In cancer, in particular, where defects in cell death are prevalent and the survival of undead cells enables progression and treatment resistance, restoration of cell death pathways is an important and achievable therapeutic goal. Finally, distinct cell death modalities may remain immunologically silent or trigger an immune response, through mechanisms that are still elusive. The 2010 Keystone Symposia meeting on Cell Death will address the normal regulation and pathogenic dysfunction of distinct cell death modalities, present new strategies for therapeutic cancer cell induction and address the immunogenicity of distinct cell death types.
Scholarship Deadline: November 12 2009
Discounted Abstract Deadline: November 12 2009
Abstract Deadline: December 10 2009
Discounted Registration Deadline: January 12 2010
We gratefully acknowledge additional support for this conference from:
AbD SerotecAstellas Pharma Inc.Cell Signaling Technology, Inc.Genentech BioOncologyInvitrogen CorporationNovus Biologicals, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Abbott Laboratories

Genentech, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA144236-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found